Vision Improvement for Legally Blind Dry AMD Patients
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50-100
SponsorOptimal Acuity Corporation
About this trial
This retrospective observational study is intended to assess the feasibility of using a nonsignificant risk device for vision improvement for legally blind dry AMD patients.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Male or Female
Any race
Patient is at least 50 years old.
Patient must have dry AMD in the study eye.
Disqualifiers
Visually significant cataract in the study eye
Presence of a visually significant posterior capsule opacity if prior cataract surgery has been performed in the study eye
Any visually significant disease process in any ocular structure other than AMD that would affect vision in the study eye
Previous corneal surgery in the study eye
Trial population
Patients with dry age-related macular degeneration an legal blindness in one or both eyes
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Clear-K Low Vision Aid Treatment
DeviceA Clear-K Low Vision Aid Device is used to produce small corneal shape and refraction changes in order to redirect light onto functional areas of the retina.
Treatment groups
40 Participants
are divided into 1 treatment groupGroup A: Legally Blind Dry AMD Patients1 intervention
Trial outcomes
Primary outcomes
1
Best spectacle-corrected distance visual acuity (BCDVA)
BCDVA measured using ETDRS eye charts
Time frame
12 months post-treatmentLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: